Amplia opens new front in ovarian cancer fight

The Sydney Morning Herald - Sep 15, 2026

Amplia Therapeutics has finalised plans for its PRROSE phase two ovarian cancer trial, with site activation and patient recruitment targeted before year-end.

Read full article

More News

Recommended

Sign Up Now

Subscribe to us for the latest news from Banking Reporter

Banking Reporter

Banking Reporter is the largest-circulated online business news in the United States, bringing a whole new genre of business journalism more up close and more incisive.